Petros Pharmaceuticals, Inc.
PTPI· OTC
PTPIPetros Pharmaceuticals, Inc.
Filed May 15, 2023 · 10-Q · 45 days after period end · 0001410578-23-001253
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Revenue | $2.52M | $2.47M |
| Net Income | -$1.39M | -$174.22K |
| EPS Diluted | -$0.66 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petros Pharmaceuticals, Inc. · CIK 1815903 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end
